参考文献/References:
[1] Wharton S,Lau DCW,Vallis M,et al.Obesity in adults:a clinical practice guideline[J].CMAJ,2020,192(31):E875-E891.DOI:10.1503/cmaj.191707.
[2] 中华医学会内分泌学分会,中华中医药学会糖尿病分会,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会,等.基于临床的肥胖症多学科诊疗共识(2021年版)[J].中华内分泌代谢杂志,2021,37(11):959-972.DOI:10.3760/cma.j.cn311282-20210807-00503.
[3] Jensen MD,Ryan DH,Apovian CM,et al.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the obesity society[J].J Am Coll Cardiol,2014,63(25 Pt B):2985-3023.DOI:10.1016/j.jacc.2013.11.004.
[4] Rothstein RI.Bariatric and metabolic endoscopy[J].Gastrointest Endosc Clin N Am,2017,27(2):xv-xvi.DOI:10.1016/j.giec.2017.01.006.
[5] Gleysteen JJ.A history of intragastric balloons[J].Surg Obes Relat Dis,2016,12(2):430-435.DOI:10.1016/j.soard.2015.10.074.
[6] Stavrou G,Shrewsbury A,Kotzampassi K.Six intragastric balloons:which to choose?[J].World J Gastrointest Endosc,2021,13(8):238-259.DOI:10.4253/wjge.v13.i8.238.
[7] Ohta M,Maekawa S,Imazu H,et al.Endoscopic intragastric balloon therapy for 15 years in Japan:results of nationwide surveys[J].Asian J Endosc Surg,2021,14(3):401-407.DOI:10.1111/ases.12881.
[8] Saunders KH,Igel LI,Saumoy M,et al.Devices and endoscopic bariatric therapies for obesity[J].Curr Obes Rep,2018,7(2):162-171.DOI:10.1007/s13679-018-0307-x.
[9] Garcia L,Vajanaphanich S,Morton JM.Comorbidity remission following intragastric dual balloon placement[J].Obes Surg,2019,29(1):353-355.DOI:10.1007/s11695-018-3564-6.
[10] De Peppo F,Caccamo R,Adorisio O,et al.The obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity[J].Endosc Int Open,2017,5(1):E59-E63.DOI:10.1055/s-0042-120413.
[11] Swei E,Almuhaidb A,Sullivan S,et al.Comparison of the efficacy and safety of the FDA-approved intragastric balloon systems in a clinical setting [J].J Clin Gastroenterol,2022,[Epub ahead of print].DOI:10.1097/MCG.0000000000001718.
[12] Farha J,Abbarh S,Haq Z,et al.Endobariatrics and metabolic endoscopy:can we solve the obesity epidemic with our scope?[J].Curr Gastroenterol Rep,2020,22(12):60.DOI:10.1007/s11894-020-00798-8.
[13] Sˇtimac D,Klobucˇar Majanovic' S,Belancˇic' A.Endoscopic treatment of obesity:from past to future[J].Dig Dis,2020,1-13.DOI:10.1159/000505394.
[14] Schulman AR,Popov V,Thompson CC.Randomized sham-controlled trials in endoscopy:a systematic review and meta analysis of adverse events[J].Gastrointestinal Endosc,2017,86(6):972-985.e3.DOI:10.1016/j.gie.2017.07.046.
[15] Lopez-Nava G,Negi A,Bautista-Castaño I,et al.Gut and metabolic hormones changes after endoscopic sleeve gastroplasty(ESG)vs.laparoscopic sleeve gastrectomy(LSG)[J].Obes Surg,2020,30(7):2642-2651.DOI:10.1007/s11695-020-04541-0.
[16] Staudenmann DA,Sui Z,Saxena P,et al.Endoscopic bariatric therapies for obesity:a review[J].Med J Aust,2021,215(4):183-188.DOI:10.5694/mja2.51179.
[17] Singh S,Bazarbashi AN,Khan A,et al.Primary obesity surgery endoluminal(POSE)for the treatment of obesity:a systematic review and meta-analysis[J].Surg Endosc,2022,36(1):252-266.DOI:10.1007/s00464-020-08267-z.
[18] Wang Y,Kassab GS.Efficacy and mechanisms of gastric volume-restriction bariatric devices[J].Front Physiol,2021,12:761481.DOI:10.3389/fphys.2021.761481.
[19] Salomone F,Sharaiha RZ,Bosˇkoski I.Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease:evidence and perspectives[J].Liver Int,2020,40(6):1262-1268.DOI:10.1111/liv.14441.
[20] de Oliveira GHP,de Moura DTH,Funari MP,et al.Metabolic effects of endoscopic duodenal mucosal resurfacing:a systematic review and meta-analysis[J].Obes Surg,2021,31(3):1304-1312.DOI:10.1007/s11695-020-05170-3.
[21] Apovian CM,Shah SN,Wolfe BM,et al.Two-year outcomes of vagal nerve blocking(vBloc)for the treatment of obesity in the ReCharge trial[J].Obes Surg,2017,27(1):169-176.DOI:10.1007/s11695-016-2325-7.
[22] Bustamante F,Brunaldi VO,Bernardo WM,et al.Obesity treatment with Botulinum Toxin-A is not effective:a systematic review and meta-analysis[J].Obes Surg,2017,27(10):2716-2723.DOI:10.1007/s11695-017-2857-5.
[23] Eisendrath P,Deviere J.Major complications of bariatric surgery:endoscopy as first-line treatment[J].Nat Rev Gastroenterol Hepatol,2015,12(12):701-710.DOI:10.1038/nrgastro.2015.151.
[24] Joo MK.Endoscopic approach for major complications of bariatric surgery[J].Clin Endosc,2017,50(1):31-41.DOI:10.5946/ce.2016.140.
[25] Neto MG,Silva LB,Grecco E,et al.Brazilian Intragastric Balloon Consensus Statement(BIBC):practical guidelines based on experience of over 40,000 cases[J].Surg Obes Relat Dis,2018,14(2):151-159.DOI:10.1016/j.soard.2017.09.528.
[26] Bulajic M,Vadalà di Prampero SF,Bosˇkoski I,et al.Endoscopic therapy of weight regain after bariatric surgery[J].World J Gastrointest Surg,2021,13(12):1584-1596.DOI:10.4240/wjgs.v13.i12.1584.
相似文献/References:
[1]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[2]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[3]胡明玥 沈山梅.棕色脂肪检测技术的研究进展[J].国际内分泌代谢杂志,2015,(01):41.[doi:10.3760/cma.j.issn.1673-4157.2015.01.010]
Hu Mingyue*,Shen Shanmei..Assessments of brown adipose tissue Hu Mingyue*,Shen Shanmei.*Medical College of Southeast University,Nanjing 210009,China[J].International Journal of Endocrinology and Metabolism,2015,(04):41.[doi:10.3760/cma.j.issn.1673-4157.2015.01.010]
[4]郑仁东,曹琳,刘克冕,等.超重或肥胖的男性2型糖尿病患者
性激素水平的研究[J].国际内分泌代谢杂志,2015,(02):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
Zheng Rendong,Cao Lin,Liu Kemian,et al.Study on sex hormone levels in overweight or obese type 2 diabetic male patients[J].International Journal of Endocrinology and Metabolism,2015,(04):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
[5]王滢,李倩.脑利钠肽与糖脂代谢的关系[J].国际内分泌代谢杂志,2015,(02):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
Wang Ying,Li Qian..Association between brain natriuretic peptide and glycolipid metabolism[J].International Journal of Endocrinology and Metabolism,2015,(04):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
[6]王兴纯,程晓芸,曲伸.代餐饮食对代谢紊乱改善的作用及其机制[J].国际内分泌代谢杂志,2015,(02):106.[doi:10.3760/cma.j.issn.1673-4157.2015.02.009]
Wang Xingchun,Cheng Xiaoyun,Qu Shen..Roles of meal replacement in the improvement of metabolic disorders and related mechanism[J].International Journal of Endocrinology and Metabolism,2015,(04):106.[doi:10.3760/cma.j.issn.1673-4157.2015.02.009]
[7]贺肴,张弛,刘瑛,等.代谢正常肥胖合并非酒精性脂肪性肝病的临床特征及内皮功能研究[J].国际内分泌代谢杂志,2015,(03):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
He Yao,Zhang Chi,Liu Ying,et al.Clinical features and endothelial function in metabolically healthy obese patients with nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2015,(04):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
[8]黄莉吉,谢绍锋,刘超.肥胖相关性肾病的研究进展[J].国际内分泌代谢杂志,2015,(03):180.[doi:10.3760/cma.j.issn.1673-4157.2015.03.010]
Huang Liji*,Xie Shaofeng,Liu Chao..Obesity-related glomerulopathy[J].International Journal of Endocrinology and Metabolism,2015,(04):180.[doi:10.3760/cma.j.issn.1673-4157.2015.03.010]
[9]刘美娟,朱惠娟,龚凤英.Glypican-，4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity，insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(04):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[10]刘琳,高鑫.肥胖与心脏结构及功能的改变[J].国际内分泌代谢杂志,2015,(03):187.[doi:10.3760/cma.j.issn.1673-4157.2015.03.012]
Liu Lin,Gao Xin..Relationship between obesity and changes of cardiac structure and function[J].International Journal of Endocrinology and Metabolism,2015,(04):187.[doi:10.3760/cma.j.issn.1673-4157.2015.03.012]